FCNYX | LUBFX | FCNYX / LUBFX | |
Total Expense Ratio | 0.20 | 0.38 | 53% |
Annual Report Gross Expense Ratio | 0.25 | 0.38 | 66% |
Fund Existence | 2 years | 9 years | - |
Gain YTD | 3.499 | 3.753 | 93% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.65B | 14.4B | 53% |
Annual Yield % from dividends | 4.55 | 4.69 | 97% |
Returns for 1 year | 4.67 | 5.14 | 91% |
Returns for 3 years | N/A | 17.75 | - |
Returns for 5 years | N/A | 16.48 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HFLGX | 12.02 | N/A | N/A |
Hennessy Cornerstone Large Growth Inv | |||
JFNIX | 74.10 | N/A | N/A |
Janus Henderson Global Life Sciences I | |||
JGRSX | 13.52 | N/A | N/A |
JHancock Global Shareholder Yield R6 | |||
BRWTX | 29.30 | N/A | N/A |
MFS Blended Research Growth Eq R3 | |||
CICEX | 66.84 | -0.16 | -0.24% |
American Funds Invmt Co of Amer 529E |